How much does Invitro Genetics Limited make?

Invitro Genetics Limited reported revenue of £9m and £1.9m profit in the year to 31 Oct 2025, according to its accounts filed at Companies House.

How many employees does Invitro Genetics Limited have?

Invitro Genetics Limited reported an average of 24 employees in the year to 31 Oct 2025.

Is Invitro Genetics Limited profitable?

Yes — Invitro Genetics Limited reported a profit of £1.9m in the year to 31 Oct 2025.

Company No. 09901425 · Incorporated 3 Dec 2015

Invitro Genetics Limited

Registered name: INVITRO GENETICS LIMITED

Part of The Cooper Companies, Inc. group

Invitro Genetics Limited made £9m revenue and £1.9m profit in the year to 31 Oct 2025.

Invitro Genetics Limited’s revenue grew 20% to £9m in the year to 31 Oct 2025, with £1.9m profit and 24 employees. The company is classified under “specialists medical practice activities” and is based in Fareham; we hold 4 years of its filed accounts.

Full P&L filedSection Q · Human health and social workSIC 86220Specialists medical practice activities

Status: Active
Location: Fareham, South East
Age: 10 yrs · since 2015
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “Coopersurgical Holdings Limited”

Latest accounts · year to 31 Oct 2025

Key figures

Operating leverageDoing more with less

Revenue

£9m

Growth ▲19.9%

Profit

£1.9m

Growth ▲573.1%

Profit margin

20.9%

Gross 60.9%

Employees

Change ▼11.1%

Profit / employee

£77.9k

Revenue/employee £373k

Profitable streak

2yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

4 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Oct 2021	31 Oct 2022	31 Oct 2024	31 Oct 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£5.5m	£5.7m	£7.5m	£9m
Cost of sales	£3.3m	£3.8m	£4.3m	£3.5m
Gross profit	£2.3m	£2m	£3.2m	£5.5m
Operating profit	£226k	−£327k	—	—
Profit before tax	£197k	−£348k	£388k	£2.5m
Profit after tax	£68.7k	−£240k	£278k	£1.9m
Profit (best available)	£68.7k	−£240k	£278k	£1.9m
Staff costs	£2.1m	£2m	£2.4m	£2.5m
Employees (average)	25	27	27	24
Ratios
Profit margin	1.2%	−4.2%	3.7%	20.9%
Gross margin	40.9%	34.4%	42.3%	60.9%
Revenue per employee	£221k	£212k	£277k	£373k
Profit per employee	£2.7k	−£8.9k	£10.3k	£77.9k
Growth (year on year)
Revenue growth	—	▲3.8%	—	▲19.9%
Profit growth	—	▼449.7%	—	▲573.1%
Headcount growth	—	▲8%	—	▼11.1%
Balance sheet — indirect signals, not revenue
Cash at bank	£1.1m	£479k	£530k	£695k
Net assets	£530k	£290k	£289k	£2.2m
Fixed assets	£1.6m	£1.4m	£858k	£1.5m
Current assets	£2.7m	£2.5m	£2.4m	£2.8m
Debtors	£823k	£1.2m	£1.3m	£1.5m
Source	Accounts · bulk data Oct 2023	Accounts · bulk data Oct 2023	FullAccounts · bulk data Jul 2026	FullAccounts · bulk data Jul 2026

Derived from the latest filing

How the business works

Profit margin: 20.9%; Profit ÷ revenue.
Gross margin: 60.9%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £373k; Revenue ÷ average employees.
Profit per employee: £77.9k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 16.5%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 16.9%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲647%; Now £2.2m
Cash at bank: ▲31%; Now £695k
Headcount: ▼11%; Now 24
Deferred income: —; Now —
Fixed assets: ▲72%; Now £1.5m

Corporate ownership

Group structure

Ownership chain

The Cooper Companies, Inc. (registered outside the UK register)ultimate parent75–100%
Coopersurgical Holdings Limited75–100%
Invitro Genetics Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (2)

Safe Obstetric Systems LimitedRev. £2m · Profit £76.3k
Research Instruments LimitedFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Oct 2025 (profit £1.9m), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.

Updated from Companies House on 12 Oct 2026

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.